SHBG and metabolic dysfunction-associated steatotic liver disease: Since SHBG is predominantly produced and regulated in the hepatocytes12,13 and its overexpression in NAFLD mouse models has been recently found to modulate hepatic lipogenesis14, we have reasoned that the apparent relationship between serum SHBG and MS may be mainly driven by the association of SHBG with NAFLD.